Stevanato Group and DWK Life Sciences Sign Non-Exclusive Distribution Agreement for EZ-fill® Platform Products
October 27 2022 - 08:01AM
Business Wire
Stevanato Group aims to expand distribution of EZ-fill® whose
proven advantages have turned its processing technology into an
industry standard for Ready-To-Use products.
Stevanato Group S.p.A. (NYSE: STVN), a leading global provider
of drug containment and delivery solutions to the pharmaceutical,
biotechnology, and life sciences industries, and DWK Life Sciences,
a leading global manufacturer and provider of precision labware as
well as primary packaging solutions for Life Science Research,
Diagnostics and Pharmaceutical markets, today announced they have
entered a non-exclusive agreement for the distribution and sale of
the EZ-fill® Ready-to-Use solutions (RTU) by Stevanato Group.
The collaboration will leverage DWK Life Sciences’ experience in
supplying a global network of laboratories and biopharma customers
to broaden the distribution of Stevanato Group’s RTU EZ-fill®
products, including EZ-fill® vials in Nest & Tub (N&T) and
trays, and EZ-fill® Cartridges in Nest & Tub.
RTU containment solutions allow pharmaceutical companies to
maximize flexibility in aseptic filling using a common filling
platform and can be integrated seamlessly into existing
pharmaceutical manufacturing filling lines.
“We are pleased to welcome DWK Life Sciences
as a distributor of our EZ-fill® platform”, said Andrea Zambon,
Corporate Business Development Senior Director of Stevanato Group.
“Through DWK Life Sciences' established, widespread and specialized
network, Stevanato Group aims to broaden the reach of our EZ-fill®
products into the pharmaceutical ecosystem, from the laboratory to
large-scale manufacturing.”
Over the last 12 years, more than 250 lines have been installed
using Stevanato Group EZ-fill® packaging technology. Adopted by
many of the leading glass primary packaging suppliers worldwide,
EZ-fill® platform has become the market’s most established choice
for pre-sterilized containers helping to ensure flexible and
streamlined processability. Accommodating both small and large
batch production, EZ-fill® can improve drug packaging quality,
reduce Total Cost of Ownership (TCO), and shorten overall
time-to-market.
Michele Mora, Managing Director & Chief
Business Officer for DWK Life Sciences, shared: “We are excited to
partner with Stevanato Group to promote the EZ-fill® portfolio and
bring the leading RTU primary packaging platform to customers in
the DWK Life Sciences global network. The introduction of the
EZ-fill® platform supports our strategy to expand best-in-class
solutions and services from “Discovery to Delivery” that enable our
customers to focus on their efforts to develop and commercialize
biopharmaceuticals and therapeutics that improve patient
lives.”
For more information, visit http://stevanatogroup.com/.
About Stevanato Group
Founded in 1949, Stevanato Group is a leading global provider of
drug containment, drug delivery and diagnostic solutions to the
pharmaceutical, biotechnology and life sciences industries. The
Group delivers an integrated, end-to-end portfolio of products,
processes and services that address customer needs across the
entire drug life cycle at each of the development, clinical and
commercial stages. Stevanato Group’s core capabilities in
scientific research and development, its commitment to technical
innovation and its engineering excellence are central to its
ability to offer value added solutions to clients. To learn more,
visit: www.stevanatogroup.com.
About DWK Life Sciences
DWK Life Sciences is the leading global manufacturer and
provider of precision labware as well as primary packaging
solutions for Life Science Research, Applied Sciences and
Diagnostics and Pharmaceutical markets.
With over 35,000 products the company’s offering includes the
most comprehensive range of premium laboratory glassware together
with a complementary portfolio of plastic products. They are
manufactured at 12 global sites and marketed under the acclaimed
brands DURAN®, WHEATON® and KIMBLE®.
Worldwide 1,900 people are dedicated to developing and
delivering superior products and services to meet the highest
expectations of customers in laboratories and production
environments around the world. To learn more, visit DWK.com.
View source
version on businesswire.com: https://www.businesswire.com/news/home/20221027005243/en/
Stevanato Group Media media@stevanatogroup.com Rachel Winship
stevanatoUS@teamlewis.com Investor Relations Lisa Miles
lisa.miles@stevanatogroup.com DWK communications@dwk.com
Stevanato (NYSE:STVN)
Historical Stock Chart
From Feb 2024 to Mar 2024
Stevanato (NYSE:STVN)
Historical Stock Chart
From Mar 2023 to Mar 2024